May Hill Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
May Hill Capital's BMY Position: Q2 2026 in Review
May Hill Capital reduced its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2026, selling an estimated $11.6K and leaving 3,793 shares worth $219K. The position accounts for 0.05% of the portfolio, ranked #235.
May Hill Capital first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $242K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- May Hill Capital held 3,793 shares of Bristol-Myers Squibb worth $219K as of Q2 2026.
- May Hill Capital sold 202 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.6K.
- Bristol-Myers Squibb made up 0.05% of May Hill Capital's portfolio in Q2 2026, its #235 holding.
- May Hill Capital first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- May Hill Capital's Bristol-Myers Squibb position peaked at $242K in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.